SCHEMBL17875883

SCHEMBL17875883

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c(c3)-c3cc(-n5c6ccccc6c6ccccc65)ccc3COC4)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
EDNRB P24530 1/20 0.36
EDNRA P25101 1/20 0.36
HDAC4 P56524 1/20 0.35
TYRO3 Q06418 1/20 0.35
NTRK2 Q16620 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PRKDC P78527 3/20 0.32
TDP2 O95551 1/20 0.31
AKR1C4 P17516 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875854 0.94 KDM4E (0.37) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875819 0.94 L3MBTL1 (0.37) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875907 0.90 PIK3CA (0.34) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875885 0.89 KDM4E (0.42) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17877777 0.88 PRKDC (0.34) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875876 0.87 KDM4E (0.47) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875884 0.87 CYP11B1 (0.40) TDP2
SCHEMBL22421873 0.86 ATM (0.42) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17875805 0.86 KDM4E (0.39) KDM4EL3MBTL1ATMEDNRBEDNRA
SCHEMBL17876286 0.85 KDM4E (0.41) KDM4EL3MBTL1ATMEDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 KDM4E 3120/4885L3MBTL1 768/4885ATM 1164/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3120/4885L3MBTL1 768/4885ATM 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.